Concord Drugs Limited (BOM:538965)
India · Delayed Price · Currency is INR 80.82
+0.51 (0.64%)
At close: Sep 4, 2026
Concord Drugs Market Cap
Concord Drugs has a market cap or net worth of 1.06 billion as of September 4, 2026. Its market cap has increased by 66.38% in one year.
Market Cap
1.06B
Enterprise Value
1.20B
Revenue
860.69M
Ranking
n/a
PE Ratio
47.00
Stock Price
80.82
ChartMarket Cap Chart
Since February 23, 2015, Concord Drugs's market cap has increased from 144.80M to 1.06B, an increase of 635.35%. That is a compound annual growth rate of 18.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 1.06B | -2.01% |
| Dec 31, 2025 | 1.09B | 188.24% |
| Dec 31, 2024 | 377.00M | -36.87% |
| Dec 29, 2023 | 597.20M | 109.83% |
| Dec 30, 2022 | 284.61M | 1.24% |
| Dec 31, 2021 | 281.11M | 40.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bal Pharma | 1.41B |
| Lactose (India) | 1.34B |
| Aayush Wellness | 1.32B |
| Speciality Medicines | 1.32B |
| Makers Laboratories | 1.13B |
| Pharmaids Pharmaceuticals | 1.10B |
| Denis Chem Lab | 981.08M |
| Asston Pharmaceuticals | 936.00M |